Načítá se...

Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine

BACKGROUND: Medications development efforts for methamphetamine-use disorder have targeted central monoamines because these systems are directly involved in the effects of methamphetamine. Buspirone is a dopamine autoreceptor and D3 receptor antagonist and partial agonist at serotonin 1A receptors,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Alcohol Depend
Hlavní autoři: Reynolds, Anna R., Strickland, Justin C., Stoops, William W., Lile, Joshua A., Rush, Craig R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5683915/
https://ncbi.nlm.nih.gov/pubmed/29028556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2017.08.038
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!